There is no precise definition of scientific research in the law. However, it is important to recognise when it is scientific research and when it is other research (e.g. opinion poll, planning and or other studies, etc.).
Perhaps the most useful in practice is the decision is from the Supreme Administrative Court (KHO 2013:181), where the characteristics of a scientific study were considered to be:
- a proper research design
- sufficient scientific competence of the authors
- the requirements of autonomy and publicity
- and the main scientific objectives of the research.
In the case in question, a company engaged in pharmaceutical epidemiological research had applied for a research authorisation under Article 28 of the Publicity Act in order to obtain anonymised access to the data contained in the prescription file of the National Social Insurance Institution (Kela) for research funded by a pharmaceutical company. The company's research plan as such met the qualitative requirements for a proper plan and the researchers had sufficient scientific qualifications. The involvement of the pharmaceutical company as a sponsor of the study did not exclude that the study could not be considered scientific. However, the study had to meet, inter alia, the requirements of autonomy and publicity.
The problem was that the survey allowed the prescription data to be used to collect information on the purchase and use of medicines that were relevant to the pharmaceutical company funding the study. The limitations of the study were not without problems and the possibility for the pharmaceutical company to influence the content of the resulting publications was not excluded. Therefore, it could not be concluded with sufficient certainty that the main objectives of the study were scientific. Because of the way in which the study was carried out and its scientific shortcomings, the Social Insurance Institution could have rejected the application for a research authorisation on the basis of Article 28 of the Publicity Act.
In order to take account of the specific characteristics of private sector studies, the Social and Health Research and Development Centre Stakes, the National Institute of Public Health, the Social Insurance Institution of Finland, the Health Insurance Institution of Finland, the Centre for Health Care and the National Institute of Occupational Health have jointly drawn up a memorandum (dated 2 June 2006) on the principles and practices for the disclosure of confidential register data. The memorandum defines what is meant by scientific research and the conditions under which confidential data may be disclosed. According to the Working Party Memorandum, the following characteristics and definitions, among others, apply to scientific research:
Autonomy means that the way in which information is generated must be independent of the opinions of the researcher, the scientific community, and outsiders. Scientific research must not be influenced by the economic, political, religious or moral desirability or undesirability of the results. The principle of public access means that the conduct and results of research must be public. The argumentation of a claim must be public so that everyone can be convinced of the legitimacy of the claim. Progress means that the truthfulness of the research increases through the acquisition of new knowledge and the elimination of inaccuracies and errors in old knowledge.
It is worth noting that the above examples have concerned the handling of confidential information.
In one decision (dn. 859/45/98) before GDPR came into effect concerning a thesis study on the services of funeral parlours carried out by students of the School of Economics and Administration of the University of Applied Sciences, the data protection ombudsman considered that the study was not scientific, but rather market research or opinion polling.